Preliminary results from a long-term study into the effects of Eli Lilly's weight loss injectable Zepbound suggest that it's extremely effective at reducing the risk of developing diabetes. In a press release about the new findings, Lilly boasted that weekly shots of tirzepatide, the active ingredient in Zepbound, reduced the risk of diabetes in 94 […]